27 Feb RIVERVEST NEWS: February Newsletter
RIVERVEST NEWSLETTERFebruary 2026 Issue RiverVest invites you to read our latest newsletter, featuring:Portfolio Company Bluejay Therapeutics Acquired by Mirum PharmaceuticalsJPM 2026 Recap: Signals are Getting ClearerRiverVest Scientific Advisor Alessandro Sette to Receive Prestigious Immunology AwardCould Excess Cortisol...